Among thyroid neoplasms, Hurthle cell tumors (HCTs) have traditionally been a distinct
diagnostic category. Hurthle cell adenomas are encapsulated follicular lesions with benign …

BACKGROUND: Though Hurthle cell tumors are considered a variant of follicular lesions,
recent data have suggested that Hurthle cell carcinomas may be more closely related to …

Context: Hurthle cell cancer (HCC) is an understudied cancer with poor prognosis.
Objective: Our objective was to elucidate the genomic foundations of HCC. Design and …

Making a histologic distinction between Hurthle cell adenomas and carcinomas sometimes
may be difficult. We analyzed a series of Hurthle cell lesions to determine whether specific …

Hurthle cell adenomas and carcinomas, characterized by the presence of oncocytic cells,
are unusual thyroid neoplasms, the treatment of which is still controversial. We analyzed …

Background Sinceret/PTCgene rearrangements are specific to papillary thyroid carcinoma
(PTC), the diagnosis of Hürthle cell PTC (HCPTC) has recently been expanded to include a …

Hürthle cell papillary thyroid carcinoma is a variant of papillary thyroid carcinoma (PTC). Its
pathologic and clinical significance has not been well documented. The authors studied the …

BACKGROUND: Hurthle cell carcinoma (HCC) is an uncommon and more aggressive
thyroid cancer. To date, there is a paucity of data at a population level. In this study …

Hurthle cell carcinoma represents about 5% of differentiated thyroid carcinomas. The
prognosis of the malignant type of the tumour is still under debate as some Authors have …

BACKGROUND: Oncocytic carcinomas (Hürthle cell carcinomas [HCCs]) are commonly
considered a subgroup of follicular thyroid carcinomas (FTCs). Recent characterization of a …